235 related articles for article (PubMed ID: 17128916)
1. [Drug-eluting stents can increase the risk of late stent thrombosis].
Skyttberg N; Linder R; Carlsson J
Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2845-7. PubMed ID: 17128916
[No Abstract] [Full Text] [Related]
2. [Late stent thromboses a neglected problem? Indications of increased risk with drug-eluting stents].
Stenestrand U
Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2838-9. PubMed ID: 17128915
[No Abstract] [Full Text] [Related]
3. Which patients receiving warfarin can be treated safely with a drug-eluting stent?
Ryding AD; Banning AP
Heart; 2008 Mar; 94(3):275-7. PubMed ID: 18276815
[No Abstract] [Full Text] [Related]
4. [How does it work? Coronary stent implantation].
Rampp T; Block M
MMW Fortschr Med; 2004 Jun; 146(23):64-5. PubMed ID: 15373140
[No Abstract] [Full Text] [Related]
5. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
[TBL] [Abstract][Full Text] [Related]
6. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
Chhatriwalla AK; Bhatt DL
Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
[No Abstract] [Full Text] [Related]
7. [Thrombosis of pharmacoactive coronary endoprothesis after stopping antiplatelet treatment].
Saidi Y; Guesmi F; Landolsi M; Trabelsi S; Khemiri K; Ounalli K; Dziri C; Houissa M
Tunis Med; 2010 Jan; 88(1):63-4. PubMed ID: 20419882
[No Abstract] [Full Text] [Related]
8. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation.
Barragan P; Bouvier JL; Roquebert PO; Macaluso G; Commeau P; Comet B; Lafont A; Camoin L; Walter U; Eigenthaler M
Catheter Cardiovasc Interv; 2003 Jul; 59(3):295-302. PubMed ID: 12822144
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
10. [Introduction to the topic: drug eluting stents. An underestimated problem in surgery].
Jähne J; Schirren J
Chirurg; 2009 Jun; 80(6):497. PubMed ID: 19434381
[No Abstract] [Full Text] [Related]
11. Stent thrombosis in the era of drug eluting stents.
Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
[TBL] [Abstract][Full Text] [Related]
12. Late stent thrombosis in brachytherapy: the role of long-term antiplatelet therapy.
Teirstein P; Reilly JP
J Invasive Cardiol; 2002 Mar; 14(3):109-14. PubMed ID: 11870263
[TBL] [Abstract][Full Text] [Related]
13. Late angiographic stent thrombosis of polymer based paclitaxel eluting stent.
Lee CH; Lim J; Low A; Tan HC; Lim YT
Heart; 2006 Apr; 92(4):551-3. PubMed ID: 16537782
[No Abstract] [Full Text] [Related]
14. Coronary artery stents: II. Perioperative considerations and management.
Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
[TBL] [Abstract][Full Text] [Related]
15. [Stents in interventional cardiology].
Grinius V; Navickas R; Unikas R
Medicina (Kaunas); 2007; 43(3):183-9. PubMed ID: 17413246
[TBL] [Abstract][Full Text] [Related]
16. Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin.
Olivier AC; Hollman JL
J Invasive Cardiol; 2006 Jun; 18(6):E185-7. PubMed ID: 16775899
[No Abstract] [Full Text] [Related]
17. Very late thrombosis after implantation of sirolimus eluting stent.
Karvouni E; Korovesis S; Katritsis DG
Heart; 2005 Jun; 91(6):e45. PubMed ID: 15894746
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous subacute stent thrombosis of two drug-eluting stents in the left anterior descending and the circumflex coronary arteries. Case report and review of the literature.
Movahed MR; Vu J; Ahsan C
J Invasive Cardiol; 2006 Jul; 18(7):E198-202. PubMed ID: 16816448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
